• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . Long COVID after SARS-CoV-2 during pregnancy in the United States

tetano

Editor, Senior Moderator
Nat Commun


. 2025 Apr 1;16(1):3005.
doi: 10.1038/s41467-025-57849-9. Long COVID after SARS-CoV-2 during pregnancy in the United States

Chengxi Zang[SUP] #[/SUP][SUP] 1 [/SUP], Daniel Guth[SUP] #[/SUP][SUP] 2 [/SUP], Ann M Bruno[SUP] #[/SUP][SUP] 3 [/SUP], Zhenxing Xu[SUP] 4 [/SUP], Haoyang Li[SUP] 4 [/SUP], Nariman Ammar[SUP] 5 6 [/SUP], Robert Chew[SUP] 7 [/SUP], Nick Guthe[SUP] 8 9 [/SUP], Emily Hadley[SUP] 7 [/SUP], Rainu Kaushal[SUP] 4 [/SUP], Tanzy Love[SUP] 10 [/SUP], Brenda M McGrath[SUP] 11 [/SUP], Rena C Patel[SUP] 12 [/SUP], Elizabeth C Seibert[SUP] 9 13 [/SUP], Yalini Senathirajah[SUP] 14 [/SUP], Sharad Kumar Singh[SUP] 2 [/SUP], Fei Wang[SUP] 4 [/SUP], Mark G Weiner[SUP] 4 [/SUP], Kenneth J Wilkins[SUP] 15 [/SUP], Yiye Zhang[SUP] 4 [/SUP], Torri D Metz[SUP] 3 [/SUP], Elaine Hill[SUP] 2 [/SUP], Thomas W Carton[SUP] 16 [/SUP]; RECOVER PCORnet EHR Consortia; RECOVER N3C EHR Consortia; RECOVER Pregnancy Consortia



Affiliations
Abstract

Pregnancy alters immune responses and clinical manifestations of COVID-19, but its impact on Long COVID remains uncertain. This study investigated Long COVID risk in individuals with SARS-CoV-2 infection during pregnancy compared to reproductive-age females infected outside of pregnancy. A retrospective analysis of two U.S. databases, the National Patient-Centered Clinical Research Network (PCORnet) and the National COVID Cohort Collaborative (N3C), identified 29,975 pregnant individuals (aged 18-50) with SARS-CoV-2 infection in pregnancy from PCORnet and 42,176 from N3C between March 2020 and June 2023. At 180 days after infection, estimated Long COVID risks for those infected during pregnancy were 16.47 per 100 persons (95% CI, 16.00-16.95) in PCORnet using the PCORnet computational phenotype (CP) model and 4.37 per 100 persons (95% CI, 4.18-4.57) in N3C using the N3C CP model. Compared to matched non-pregnant individuals, the adjusted hazard ratios for Long COVID were 0.86 (95% CI, 0.83-0.90) in PCORnet and 0.70 (95% CI, 0.66-0.74) in N3C. The observed risk factors for Long COVID included Black race/ethnicity, advanced maternal age, first- and second-trimester infection, obesity, and comorbid conditions. While the findings suggest a high incidence of Long COVID among pregnant individuals, their risk was lower than that of matched non-pregnant females.


 
Back
Top Bottom